Skip to content

Double your impact during the Annual Ataxia Research Drive! Donate before December 31st to have your gift matched!  LEARN MORE!

NAF

Top 5 Holiday Gift Ideas for Individuals with Ataxia

Guest Author: Day Undefined Welcome to Day Undefined’s Holiday Gift Guide for the National Ataxia Foundation – taking a fun twist on some of our favorite products. We hope it might spark ideas for useful, thoughtful, and accessible gifts for yourself or a loved one. Of course, while our team Read More…

NAF is Hiring a Clinical Research Coordinator

NAF is hiring a full time Clinical Research Coordinator. This person will be responsible for supporting the Clinical Operations Branch of the Research Department. This position primarily focuses on coordinating the NAF-sponsored Natural History Study titled Clinical Research Consortium for the Study of Cerebellar Ataxias (CRC-SCA). They will independently manage Read More…

Dr. Tee: The Journey of a Pioneer in Ataxia Research and Patient Care

While some begin their careers with a specific specialization – ready to focus on making a difference in a certain field – Dr. Tetsuo Ashizawa’s path to becoming an internationally acclaimed physician scientist specializing in Ataxia was anything but predetermined. Born in Tokyo in 1948, Dr. Tee, as he prefers Read More…

NAF is Hiring a Regional Development Manager

NAF is hiring a full time Regional Development Manager for the Western region of the United States. This person will be responsible for generating revenue via traditional non-profit revenue streams including major gifts, recurring gifts, planned gifts, individual giving, corporate and foundation giving, memorials, third party fundraising events and sponsorship Read More…

Community Response Regarding Troriluzole Delivered to FDA

Last month we asked for your feedback about the FDA’s decision to refuse to file Biohaven’s NDA for troriluzole. More than 3,000 people stepped up to make their voices heard! 97% of respondents agree that the FDA should apply regulatory flexibility and accept the NDA filing for troriluzole for a Read More…

NAF Team Member Joins Climbing Kili for a Cure

Pictured: Tanoa (left) and Mike (right) at NAF’s 2023 Annual Ataxia Conference in Las Vegas. My name is Tanoa and I am NAF’s Social Media Coordinator. I am proud to announce that I will be climbing Mount Kilimanjaro alongside Mike De Rosa this October! I will be there to document Read More…

Unraveling Ancestry: Mary Hogan’s Journey

Step into the world of Mary Hogan, where genealogy goes far beyond a mere hobby and leads to learning about a pervasive genetic disorder called SCA27B. A Family Affected – The “Darby Glide” Many of us have logged onto Ancestry.com and tinkered around for a few hours. We’ve seen the Read More…

Tell Us Why You Think Ataxia Deserves Regulatory Flexibility

Thank you for submitting your comments for the FDA! NAF gathered feedback from the Ataxia community to submit to the FDA. We’re concerned with the FDA’s decision to refuse to file Biohaven’s new drug application (NDA) for troriluzole without a full review of the clinical trial results. Read our full statement Read More…

Translate »

2

Donations needed this hour to reach our goal!

You’ve been such a great friend by staying connected with NAF. If it’s not too much to ask, would you consider giving today so that our anonymous donors can match your gift?